Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Bacteria develop resistance from rivals - study
The overuse of antibiotics may not be exclusively responsible for antibiotic resistance.

Research works to tackle antibiotic resistance

The overuse of antibiotics may not be exclusively responsible for antibiotic resistance, according to new research.

The study by the University of Basel found that bacteria can develop resistance to antibiotics from their competitors.
Writing in Cell Reports, researchers show that some bacteria inject a toxic cocktail into their rivals leading to cell lysis and death.

Researchers also found that if the released material contains certain drug-resistant genes, the specific resistance can be bestowed upon the new owner. As such, the antibiotic is no longer effective and the bacteria can reproduce.

“Some of these toxic proteins kill the bacterial competition very effectively, but do not destroy the cells,” explained Professor Marek Basler, who led the research. “Others severely damage the cell envelope, which leads to less of the attacked bacteria and hence the release of its genetic material.”

In the study, the researchers analysed the drug-resistant bacterium Acinetobacter baumanni - a typical hospital germ that originated during the Iraq war. The bacteria is also known as the ‘Iraq bug’ because it was spread by American soldiers returning home from combat.

The team found that the emergence and spread of multidrug resistance could be attributed - amongst other things - to the skills of certain bacteria. First, the bacteria combat their rivals by injecting them with toxic proteins - or effectors - using the type VI secretion system (T6SS), a poison syringe. Second, they are able to uptake and reuse the released genetic material.

In the model Acinetobacter baylyi, a close relative of the Iraq bug, Professor Basler’s team identified five differently acting toxic effectors.

“For the bacteria it makes absolute sense to produce not only a single toxin, but a cocktail of various toxins with different effects,” Basler explains. “This increases the likelihood that the rival can be successful and in some cases also lysed to release their DNA.”

Professor Basler added that the T6SS 'can also be found in other pathogens such as those which cause pneumonia or cholera'.

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.